Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10190Neoplasms 7819Carcinoma, Non-Small-Cell Lung 5763Prostatic Neoplasms 5032Colorectal Neoplasms 4608Lung Neoplasms 3727Leukemia, Myeloid, Acute 3104Neoplasm Metastasis 3086Multiple Myeloma 3083Pancreatic Neoplasms 2846Melanoma 2654Ovarian Neoplasms 2578Lymphoma 2571Carcinoma, Hepatocellular 2483Stomach Neoplasms 2331Recurrence 2229Head and Neck Neoplasms 2106Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia 2013Brain Neoplasms 1906Glioblastoma 1799Colonic Neoplasms 1791Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1720Uterine Cervical Neoplasms 1695Lymphoma, Follicular 1655Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Large B-Cell, Diffuse 1598Carcinoma, Renal Cell 1579

Interventions

Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Laparoscopic Surgery × Clear all
NCT07458295 2026-03-17

The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology

Beijing Tiantan Hospital

Phase NA Recruiting
110 enrolled

Laparoscopic Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡